EBV

Clinical trials for EBV explained in plain language.

Never miss a new study

Get alerted when new EBV trials appear

Sign up with your email to follow new studies for EBV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1

Could this mRNA vaccine stop the virus behind mono and certain cancers?

⭐️ VACCINE ⭐️ Not yet recruiting

This early-stage study tests a new mRNA vaccine called VXCO-102 in 45 healthy young adults aged 18 to 25. The goal is to see if the vaccine is safe and triggers an immune response against Epstein-Barr virus (EBV), which causes mononucleosis and is linked to some cancers. Particip…

Matched conditions: EBV

Phase: PHASE1 • Sponsor: Vaccine Company, Inc. • Aim: ⭐️ VACCINE ⭐️

Last updated May 17, 2026 04:10 UTC

EBV

Get alerted when new EBV trials appear

Could this mRNA vaccine stop the virus behind mono and certain cancers?